Drug profile · INN
artesunate
GARSUN
artesunate (GARSUN) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved EMA: approved Antiparasitic products (P01) P01BE03
US status approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — artesunate
- US status
- approved
- Class
- Antiparasitic products (P01)
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 6
- Data quality
- 0.84
Quick answer
artesunate (GARSUN) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN artesunate
Brand GARSUN
Mechanism Unknown
Therapeutic class Antiparasitic products (P01)
Route INTRAVENOUS
Formulation POWDER
ATC code P01BE03
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is artesunate?
artesunate (GARSUN) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for artesunate?
GARSUN is a marketed brand name for artesunate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of artesunate?
artesunate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.